title: Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials.
authors.affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. csimmons@oucru.org
authors.forename: Cameron P
authors.initials: CP
authors.lastname: Simmons
authors.forename: Marcel
authors.initials: M
authors.lastname: Wolbers
authors.forename: Minh Nguyet
authors.initials: MN
authors.lastname: Nguyen
authors.forename: Jamie
authors.initials: J
authors.lastname: Whitehorn
authors.forename: Pei Yong
authors.initials: PY
authors.lastname: Shi
authors.forename: Paul
authors.initials: P
authors.lastname: Young
authors.forename: Rosemary
authors.initials: R
authors.lastname: Petric
authors.forename: Van Vinh Chau
authors.initials: VV
authors.lastname: Nguyen
authors.forename: Jeremy
authors.initials: J
authors.lastname: Farrar
authors.forename: Bridget
authors.initials: B
authors.lastname: Wills
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D035843:Biomedical Research / Q000379:methods*; D003715:Dengue / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards*
chemical_list: D000998:Antiviral Agents